Elucidating the specific pharmacological mechanism of action (MOA) of naturally developing compounds may be challenging. Although Tarselli et al. (60) formulated the 1st de novo synthetic pathway to conolidine and showcased this By natural means occurring compound successfully suppresses responses to the two chemically induced and inflammation-deri… Read More